Introduction: Scaling up of antiretroviral therapy (ART) to HIV+ pregnant women is crucial for the elimination of HIV infection in children. The aim of this study was to evaluate the feasibility and effectiveness of triple ART for Prevention of Mother-to Child Transmission (PMTCT) in Cameroon. Methods: HIV-positive pregnant women attending the DREAM Centre of Dschang, Cameroon for prenatal care were enrolled in a prospective cohort study, and received ART until the end of breastfeeding or indefinitely if their CD4 count was <350mm(3). Infants were evaluated for HIV infection at 1, 6 and 12 months of age. Results: A total of 298 women were enrolled. Among them, 152 were already on established ART. Women were followed until 6 months after delivery with a retention rate of 92.6%. Eight women died. Those with a CD4 count <350 cells/mm(3) during pregnancy had the highest mortality risk (RR 2.53; 95% CL= 1.86-3.44). The HIV transmission rate was 1.2% at 12 months with an HIV free survival of 91%. In the proportional Cox regression analysis, the following factors were positively associated with infant mortality: maternal CD4< 350 cells/mm(3), no breastfeeding in the first 6 months of life, weight-for-age z score < -2. Conclusion: Results confirm the feasibility and effectiveness of the implementation of Option B, with very low rates of HIV MTC transmission, and potential benefits to the health of mothers and infants with earlier initiation of ART. Breastfeeding again demonstrates to be highly beneficial for the growth and survival of HIV exposed children.

Altan, A., Taafo, F., Fopa, F., Buonomo, E., Marazzi, M.c., Nielsen-Saines, K., et al. (2016). An assessment of option b implementation for the prevention of mother to child transmission in dschang, cameroon: Results from the dream (drug resource enhancement against aids and malnutrition) cohort. THE PAN AFRICAN MEDICAL JOURNAL, 23(72) [10.11604/pamj.2016.23.72.7958].

An assessment of option b implementation for the prevention of mother to child transmission in dschang, cameroon: Results from the dream (drug resource enhancement against aids and malnutrition) cohort

Buonomo E.;Orlando S.;Scarcella P.;Mancinelli S.;Palombi L.
2016

Abstract

Introduction: Scaling up of antiretroviral therapy (ART) to HIV+ pregnant women is crucial for the elimination of HIV infection in children. The aim of this study was to evaluate the feasibility and effectiveness of triple ART for Prevention of Mother-to Child Transmission (PMTCT) in Cameroon. Methods: HIV-positive pregnant women attending the DREAM Centre of Dschang, Cameroon for prenatal care were enrolled in a prospective cohort study, and received ART until the end of breastfeeding or indefinitely if their CD4 count was <350mm(3). Infants were evaluated for HIV infection at 1, 6 and 12 months of age. Results: A total of 298 women were enrolled. Among them, 152 were already on established ART. Women were followed until 6 months after delivery with a retention rate of 92.6%. Eight women died. Those with a CD4 count <350 cells/mm(3) during pregnancy had the highest mortality risk (RR 2.53; 95% CL= 1.86-3.44). The HIV transmission rate was 1.2% at 12 months with an HIV free survival of 91%. In the proportional Cox regression analysis, the following factors were positively associated with infant mortality: maternal CD4< 350 cells/mm(3), no breastfeeding in the first 6 months of life, weight-for-age z score < -2. Conclusion: Results confirm the feasibility and effectiveness of the implementation of Option B, with very low rates of HIV MTC transmission, and potential benefits to the health of mothers and infants with earlier initiation of ART. Breastfeeding again demonstrates to be highly beneficial for the growth and survival of HIV exposed children.
Pubblicato
Rilevanza internazionale
Articolo
Sì, ma tipo non specificato
Settore MED/42 - Igiene Generale e Applicata
Settore MED/17 - Malattie Infettive
English
Cameroon; HIV; Option B; breastfeeding; mother-to-child transmission (MTCT); Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Breast Feeding; CD4 Lymphocyte Count; Cameroon; Cohort Studies; Feasibility Studies; Female; Follow-Up Studies; HIV Infections; Humans; Infant; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Proportional Hazards Models; Prospective Studies; Young Adult
http://www.panafrican-med-journal.com/content/article/23/72/full/
Altan, A., Taafo, F., Fopa, F., Buonomo, E., Marazzi, M.c., Nielsen-Saines, K., et al. (2016). An assessment of option b implementation for the prevention of mother to child transmission in dschang, cameroon: Results from the dream (drug resource enhancement against aids and malnutrition) cohort. THE PAN AFRICAN MEDICAL JOURNAL, 23(72) [10.11604/pamj.2016.23.72.7958].
Altan, Amd; Taafo, F; Fopa, F; Buonomo, E; Marazzi, Mc; Nielsen-Saines, K; Orlando, S; Scarcella, P; Ciccacci, F; Mancinelli, S; Lio, Mms; Palombi, L
Articolo su rivista
File in questo prodotto:
File Dimensione Formato  
2016 An assessment of option B implementation for the prevention of mother to child transmission in Dschang.pdf

non disponibili

Licenza: Non specificato
Dimensione 397.93 kB
Formato Adobe PDF
397.93 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/195432
Citazioni
  • ???jsp.display-item.citation.pmc??? 7
  • Scopus 9
  • ???jsp.display-item.citation.isi??? 10
social impact